Jörg Neermann

Jörg Neermann is a seasoned professional with extensive experience in the biotechnology and venture capital sectors. Currently serving as a Venture Partner at Vorwerk Ventures since 2023, Jörg has held significant roles including Board Member at Immunic Therapeutics and Immunic AG, as well as Chairman of the Board at Immunic AG. Previous board memberships include Vivoryon Therapeutics N.V., Imcyse SA, ViCentra, Kuros Biosciences, and Curetis AG. Jörg also served as CEO of Curexsys from 2021 to 2022 and was a Partner at LSP from 2007 to 2021. Jörg's academic background includes a Ph.D. in Biotechnology and Economics from Technische Universität Braunschweig, coupled with further education at the Massachusetts Institute of Technology.